نتایج جستجو برای: hereditary breast cancer

تعداد نتایج: 1055993  

Journal: :Journal of Genetic Medicine 2012

2017
Marcia Cruz-Correa Julyann Pérez-Mayoral Julie Dutil Miguel Echenique Rafael Mosquera Keila Rivera-Román Sharee Umpierre Segundo Rodriguez-Quilichini Maria Gonzalez-Pons Myrta I. Olivera Sherly Pardo

Hereditary cancer predisposition syndromes comprise approximately 10% of diagnosed cancers; however, familial forms are believed to account for up to 30% of some cancers. In Hispanics, the most commonly diagnosed hereditary cancers include colorectal cancer syndromes such as, Lynch Syndrome, Familial Adenomatous Polyposis, and hereditary breast and ovarian cancer syndromes. Although the inciden...

Journal: :Український радіологічний та онкологічний журнал 2020

Journal: :Pathobiology : journal of immunopathology, molecular and cellular biology 2008
J Palacios M J Robles-Frías M A Castilla M A López-García J Benítez

Hereditary breast cancer arising in carriers of mutations in the BRCA1 and BRCA2 genes differs from sporadic breast cancer and from non-BRCA1/2 familial breast carcinomas. Most BRCA1 carcinomas have the basal-like phenotype and are high-grade, highly proliferating, estrogen receptor-negative and HER2-negative breast carcinomas, characterized by the expression of basal markers such as basal kera...

2017
Wenjing Jian Kang Shao Qi Qin Xiaohong Wang Shufen Song Xianming Wang

Background Breast cancer develops as a result of multiple gene mutations in combination with environmental risk factors. Causative variants in genes such as BRCA1 and/or BRCA2 have been shown to account for hereditary nature of certain breast cancers. However,other genes, such as ATM, PALB2, BRIP1, CHEK, BARD1, while lower in frequency, may also increase breast cancer risk. There are few studie...

2017
Manoj R Kumar

Breast cancer is characterized by uncontrolled growth of malignant cells in the mammary epithelial tissue. The etiology of breast cancer is poorly understood and in spite of substantial therapeutic advances, breast cancer treatment remains as an unsolved issue. Though few genetic markers for hereditary breast cancer have been identified, the etiology of sporadic breast cancer remains poorly und...

2007
Teresa Tapia Maricarmen Vallejos Susan Smalley Pilar Carvallo

Besides BRCA1 and BRCA2, two genes accounting for a small proportion of breast cancer cases, ATM has been widely proposed as a low-penetrance susceptibility gene. Several nucleotide changes have been proposed to be associated with breast cancer, still remaining a high controversy in this sense. We screened the ATM gene in 94 breast cancer patients selected from 78 high-risk families, not presen...

2018

Breast cancer refers to several types of neoplasm arising from breast tissue, the most common being adenocarcinoma of the cells lining the terminal duct lobular unit. Breast cancer is the most prevalent cancer in women all around the globe, and is the second leading cause of cancer deaths in women. However, the prognosis is good if detected early. The overall 5-year relative survival is 88% in ...

Journal: :Hereditary cancer in clinical practice 2016
Gabriela C Fernandes Rodrigo A D Michelli Cristovam Scapulatempo-Neto Edenir I Palmero

INTRODUCTION Breast cancer (BC) is an important public health problem worldwide. In Brazil, breast cancer is the most frequently diagnosed tumor and the leading cause of cancer death in women. Hereditary cancer represents approximately 5 to 10 % of BC cases. Even outside the hereditary cancer context, the presence of polymorphisms acting as genetic modifiers may contribute to a better or worse ...

Journal: :The Journal of molecular diagnostics : JMD 2015
Daniel Trujillano Maximilian E R Weiss Juliane Schneider Julia Köster Efstathios B Papachristos Viatcheslav Saviouk Tetyana Zakharkina Nahid Nahavandi Lejla Kovacevic Arndt Rolfs

Genetic testing for hereditary breast and/or ovarian cancer mostly relies on laborious molecular tools that use Sanger sequencing to scan for mutations in the BRCA1 and BRCA2 genes. We explored a more efficient genetic screening strategy based on next-generation sequencing of the BRCA1 and BRCA2 genes in 210 hereditary breast and/or ovarian cancer patients. We first validated this approach in a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید